211 related articles for article (PubMed ID: 31177803)
1. What Is the Evidence for Co-trimoxazole, Clindamycin, Doxycycline, and Minocycline in the Treatment of Methicillin-Resistant
Hong J; Ensom MHH; Lau TTY
Ann Pharmacother; 2019 Nov; 53(11):1153-1161. PubMed ID: 31177803
[No Abstract] [Full Text] [Related]
2. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections.
Cunha BA
Int J Antimicrob Agents; 2013 Dec; 42(6):497-9. PubMed ID: 24126085
[TBL] [Abstract][Full Text] [Related]
3. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Lawrence KR; Golik MV; Davidson L
Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
[TBL] [Abstract][Full Text] [Related]
4. State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Epps QJ; Epps KL; Young DC; Zobell JT
Pediatr Pulmonol; 2020 Jan; 55(1):33-57. PubMed ID: 31609097
[TBL] [Abstract][Full Text] [Related]
5. Is methicillin-resistant Staphylococcus aureus pneumonia epidemiology and sensitivity changing?
Diaz E; Fernandez IM; Jimenez L; Rodriguez M; Surani S
Am J Med Sci; 2012 Mar; 343(3):196-8. PubMed ID: 21817882
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Grim SA; Rapp RP; Martin CA; Evans ME
Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection.
Talan DA; Lovecchio F; Abrahamian FM; Karras DJ; Steele MT; Rothman RE; Krishnadasan A; Mower WR; Hoagland R; Moran GJ
Clin Infect Dis; 2016 Jun; 62(12):1505-1513. PubMed ID: 27025829
[TBL] [Abstract][Full Text] [Related]
8. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.
Daum RS; Miller LG; Immergluck L; Fritz S; Creech CB; Young D; Kumar N; Downing M; Pettibone S; Hoagland R; Eells SJ; Boyle MG; Parker TC; Chambers HF;
N Engl J Med; 2017 Jun; 376(26):2545-2555. PubMed ID: 28657870
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Doxycycline or Minocycline to Sulfamethoxazole-Trimethoprim for Treatment of
Alhayani T; Philpott CD; Liao S; Gentene AJ; Mueller EW
Ann Pharmacother; 2024 Jan; 58(1):21-27. PubMed ID: 37125743
[TBL] [Abstract][Full Text] [Related]
10. A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience.
Vicetti Miguel CP; Mejias A; Leber A; Sanchez PJ
PLoS One; 2019; 14(2):e0212029. PubMed ID: 30753206
[TBL] [Abstract][Full Text] [Related]
11.
Guzek A; Rybicki Z; Tomaszewski D
Indian J Med Microbiol; 2018; 36(1):119-120. PubMed ID: 29735840
[TBL] [Abstract][Full Text] [Related]
12. The use of trimethoprim and sulfamethoxazole (TMP-SMX) in dermatology.
Michałek K; Lechowicz M; Pastuszczak M; Wojas-Pelc A
Folia Med Cracov; 2015; 55(1):35-41. PubMed ID: 26774630
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.
Frei CR; Miller ML; Lewis JS; Lawson KA; Hunter JM; Oramasionwu CU; Talbert RL
J Am Board Fam Med; 2010; 23(6):714-9. PubMed ID: 21057066
[TBL] [Abstract][Full Text] [Related]
14. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
Phillips S; MacDougall C; Holdford DA
Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
Fusco NM; Toussaint KA; Prescott WA
Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
[TBL] [Abstract][Full Text] [Related]
16. Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities.
Braun L; Craft D; Williams R; Tuamokumo F; Ottolini M
Pediatr Infect Dis J; 2005 Jul; 24(7):622-6. PubMed ID: 15999004
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulfamethoxazole for the prevention of methicillin-resistant Staphylococcus aureus pneumonia in severely burned patients.
Kimura A; Mochizuki T; Nishizawa K; Mashiko K; Yamamoto Y; Otsuka T
J Trauma; 1998 Aug; 45(2):383-7. PubMed ID: 9715201
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study.
Forcade NA; Parchman ML; Jorgensen JH; Du LC; Nyren NR; Treviño LB; Peña J; Mann MW; Muñoz A; Treviño SB; Mortensen EM; Wickes BL; Pollock BH; Frei CR
J Am Board Fam Med; 2011; 24(5):543-50. PubMed ID: 21900437
[TBL] [Abstract][Full Text] [Related]
19. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
de Górgolas M; Avilés P; Verdejo C; Fernández Guerrero ML
Antimicrob Agents Chemother; 1995 Apr; 39(4):953-7. PubMed ID: 7786002
[TBL] [Abstract][Full Text] [Related]
20. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
